Advisor Net Financial, Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Advisor Net Financial, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 04, 2022	SELL	$144.95 - $152.29 $42,470 - $44,620	-293 Reduced 6.66%	4,108 $621,000
Q2 2022 Jul 07, 2022	SELL	$83.14 - $145.99 $415 - $729	-5 Reduced 0.11%	4,401 $641,000
Q1 2022 Apr 14, 2022	BUY	$110.08 - $142.92 $7,705 - $10,004	70 Added 1.61%	4,406 $522,000
Q4 2021 Jan 19, 2022	BUY	$99.73 - $148.48 $213,023 - $317,153	2,136 Added 97.09%	4,336 $598,000
Q2 2021 Jul 06, 2021	BUY	$65.78 - $105.02 $144,716 - $231,044	2,200 New	2,200 $214,000
Q4 2020 Feb 04, 2021	SELL	$65.07 - $98.24 $9,760 - $14,736	-150 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$27.51 - $57.29 $4,126 - $8,593	150 New	150 $5,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.